trial

Past Pain Experience and Perception of Experimental Pain

NCTId NCT01575912

as of 2026-07-01

Add to landscape Monitor this Ask about this

at a glance

Phase — · Completed

Enrollment 92 (actual)

Sponsored by Centre Hospitalier Esquirol

Primary completion 2014-01

Synthesized from structured facts only — each point cited above.

Design & status

Phase

—

Status

Completed

Enrollment

92 (actual)

Study type

Observational

Allocation

—

Model

—

Masking

—

Start

2012-03

Primary completion

2014-01

Eligibility

ALL · 18 Years · 60 Years

Interventions & indications

Drugs

experimental pain tests

Indications

Pain Depressive Disorder, Major Schizophrenia Major Depression Schizophrenia

Investigators

Dominique Malauzat, MDPrincipal Investigator

Sites

1 total

Limoges, France

Facts & assertions

4 sourced

Enrollment

Phase

Primary Completion Date

2014-01

Status

COMPLETED

relationships

The graph out of here

drug

experimental pain tests

drug

lead_sponsor

Centre Hospitalier Esquirol

company

indication

Pain

indication

Depressive Disorder, Major

indication

Schizophrenia

indication

investigator

Dominique Malauzat, MD

person